Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Frontiers in Endocrinology
|
June 13, 2022
Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Bin Zhou, Yetan Shi, Rongrong Fu, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 9, 2024
Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies
Xiang Zhao, Weizhu Qian, Sheng Hou, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
July 28, 2021
Efficacy of Neoadjuvant Therapy in Improving Long-Term Survival of Patients with Resectable Rectal Cancer: A Meta-Analysis
Xinlong Li, Xiangyuan Li, Rongrong Fu, et al.
Pharmaceutical Development and Technology
|
January 17, 2024
Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes
Rongrong Fu, Rui Chang, Andong Peng, et al.
Molecular Pharmaceutics
|
May 3, 2023
Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors
Rui Chang, Rongrong Fu, Yujiao Huang, et al.
Molecular Pharmaceutics
|
February 7, 2025
Correction to "Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors"
Rui Chang, Rongrong Fu, Yujiao Huang, et al.
BMC Oral Health
|
November 12, 2025
Global burden and trends of common head and neck cancers between 1990 and 2021: findings from the Global Burden of Disease Study 2021
Jianli Lin, Bingqin Xie, Xuehan Yi, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 3, 2024
Highly drug/target-tolerant neutralizing antibody (NAb) assay development through target-based drug depletion and drug-based NAb extraction for an anti-EGFR therapeutic monoclonal antibody
Rongrong Fu, Jin Xu, Qingcheng Guo, et al.
Mbio
|
February 13, 2014
Heteroresistance at the single-cell level: adapting to antibiotic stress through a population-based strategy and growth-controlled interphenotypic coordination
Xiaorong Wang, Yu Kang, Chunxiong Luo, et al.
Frontiers in Bioengineering and Biotechnology
|
April 8, 2024
Improving product quality and productivity of an antibody-based biotherapeutic using inverted frustoconical shaking bioreactors
Xuekun Wang, Jin Xu, Qingcheng Guo, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Frontiers in Endocrinology
|
June 13, 2022
Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Bin Zhou, Yetan Shi, Rongrong Fu, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 9, 2024
Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies
Xiang Zhao, Weizhu Qian, Sheng Hou, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
July 28, 2021
Efficacy of Neoadjuvant Therapy in Improving Long-Term Survival of Patients with Resectable Rectal Cancer: A Meta-Analysis
Xinlong Li, Xiangyuan Li, Rongrong Fu, et al.
Pharmaceutical Development and Technology
|
January 17, 2024
Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes
Rongrong Fu, Rui Chang, Andong Peng, et al.
Molecular Pharmaceutics
|
May 3, 2023
Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors
Rui Chang, Rongrong Fu, Yujiao Huang, et al.
Molecular Pharmaceutics
|
February 7, 2025
Correction to "Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors"
Rui Chang, Rongrong Fu, Yujiao Huang, et al.
BMC Oral Health
|
November 12, 2025
Global burden and trends of common head and neck cancers between 1990 and 2021: findings from the Global Burden of Disease Study 2021
Jianli Lin, Bingqin Xie, Xuehan Yi, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 3, 2024
Highly drug/target-tolerant neutralizing antibody (NAb) assay development through target-based drug depletion and drug-based NAb extraction for an anti-EGFR therapeutic monoclonal antibody
Rongrong Fu, Jin Xu, Qingcheng Guo, et al.
Mbio
|
February 13, 2014
Heteroresistance at the single-cell level: adapting to antibiotic stress through a population-based strategy and growth-controlled interphenotypic coordination
Xiaorong Wang, Yu Kang, Chunxiong Luo, et al.
Frontiers in Bioengineering and Biotechnology
|
April 8, 2024
Improving product quality and productivity of an antibody-based biotherapeutic using inverted frustoconical shaking bioreactors
Xuekun Wang, Jin Xu, Qingcheng Guo, et al.
Page
of 10